web analytics
10.3 C
Munich
Monday, September 20, 2021

MC Endeavors, Inc. (OTCMKTS: MSMY) Blue Sky Breakout as CBD Lab Pioneer Signs Contract with Dr. CBD & Prepares to Hit Big Box Retail Stores in Southern California

MC Endeavors, Inc. (OTCMKTS: MSMY) is moving northbound with power in recent days having surpassed previous highs the stock is now on a blue-sky breakout. MSMY is quickly emerging as a volume leader in small caps attraction legions of new shareholders including some heavy hitters on the OTC. Currently under heavy accumulation MSMY is moving steadily northbound with many new investors buying in every day. MSMY is looking to blaze a path along the likes of Enzolytics or Tesoro and break out into a whole new dimension – Tesoro went to multi dollars – and MSMY has much stronger fundamentals then Tesoro ever did.  

MSMY is led by high level executive Steven Mazurek who has a history of success and has been working hard behind the scenes with no dilution in over 2 years. Recently MSMY up listed to “pink current” status on OTC Markets and already has an eye on OTCQB. The Company has been making big moves having just signed a 1yr contract with Dr. CBD the number 1 brand on WeedMaps and has a contract with Susan Komen Cancer Org. and will be in big box retail stores in Southern California and test market is going very well. MSMY wholly owned subsidiary Eclipse Liquids is one of only 34 AEMSA certified and FDA registered clean room laboratories and production facilities for eLiquid private label manufacturing in the world.  

MC Endeavors, Inc. (OTCMKTS: MSMY) and its wholly owned subsidiary Eclipse Liquids is the parent company of CBD Liquid Labs operating out of Aliso Viejo, California. Eclipse Liquids provides clients with turnkey CBD product production services including R&D, component sourcing, custom formulation, brand and labels design, label printing, contract and wholesale, custom private label manufacturing and lab certified 3rd party testing to ensure a full service, one stop shop experience. Eclipse Liquids brings CBD product manufacturing solutions to a breadth of markets, including consumer health and wellness, personal care and cosmetics, pharmaceuticals and nutraceuticals, pets, sports, lifestyle fitness and e-liquid tobacco; helping customers introduce innovative products, reduce their time to market, and enhance their overall competitiveness. 

Eclipse Liquids is one of only 34 AEMSA certified and FDA registered clean room laboratories and production facilities for eLiquid private label manufacturing in the world. Through years of honing its manufacturing processes, developing and innovating new products and building a loyal and dedicated staff, Eclipse has grown to become a leader in the CBD Product manufacturing industry. Specializing in private label premium CBD products serving the needs of small-scale businesses to large multi-national companies. The Company offers a broad range of capabilities, from custom recipe development with full production and manufacturing, to confidential private labeling of your branded CBD products. 

MSMY is led by high level executive Steven Mazurek who has a history of success and has been working hard behind the scenes with no dilution in over 2 years. Recently MSMY up listed to “pink current” status on OTC Markets after filing all required financials to OTC Markets for the Company’s December 31, 2019, and 2020 fiscal years as well as First Quarter Financials ending March 31, 2021. Mr. Mazurek has stated he will take MSMY to fully reporting OTCQB once current has been achieved. He has also been beefing up the management team recently announcing Michele King as the Director of Sales. King joins Eclipse Liquids from Enhanced Tech and arrives at a time of rapid expansion. The Company is currently hiring with positions open for a Sales manager, print equipment operator and manufacturing, mixing and product assistant available.  

MSMY acquired Eclipse last year; CEO Steven Mazurek said at the time: “We are very pleased with the results for the first three quarters of the year and we are on track to meet our projections of $1.8 – $2.0 million in revenues for the fiscal year 2019. Since we started selling CBD products in Jan of 2019, this product line is now the fastest growing segment of our business with Q3 over Q2 revenue growth of 32% and Q4 over Q3 growth projected at over 60%. With the new equipment we have already ordered, and the planned product expansion, we expect next year to continue to show significant Q over Q Revenue Growth. We are profitable and reinvesting our profits into additional equipment to meet the growing demands and requests of our clients.”

To Find out the inside Scoop on MSMY Subscribe to Microcapdaily.com Right Now by entering your Email in the box below

MSMY

On August 5 MSMY announced a huge win for longtime client, Dr. CBD, who recently signed a one-year contract as the exclusive CBD brand for the largest breast cancer organization in the United States, the Susan G. Komen Foundation. 

Rudy Padrol, CEO of Dr. CBD, started in 2018 and through the hard work of Mr. Padrol and the Eclipse team, his ideas became reality. Shortly thereafter, Dr. CBD collaborated with and became the first CBD brand on Weedmaps. With the new exclusive Komen contract, Dr. CBD products are now being testing in Walgreens, Albertsons, Pavilions & Costcos across Southern California. While the data is still coming in from the test locations, Eclipse Liquids is very optimistic with the unlimited potential of the Dr. CBD brand. 

“Dr. CBD is a story about hope,” says Rudy Padrol, from Dr. CBD. “Our goal is doing CBD the ‘right’ way.” With Mr. Padrol’s perseverance overcoming addiction and his dedication to helping others, Eclipse is proud to be a part of this journey with Mr. Padrol & his team and we are anticipating amazing growth very soon. 

For more on MSMY Subscribe Right Now!

MSMY is moving northbound with power in recent days having surpassed previous highs the stock is now on a blue-sky breakout. MSMY is quickly emerging as a volume leader in small caps attraction legions of new shareholders including some heavy hitters on the OTC. Currently under heavy accumulation MSMY is moving steadily northbound with many new investors buying in every day. MSMY is looking to blaze a path along the likes of Enzolytics or Tesoro and break out into a whole new dimension – Tesoro went to multi dollars – and MSMY has much stronger fundamentals then Tesoro ever did. MSMY is led by high level executive Steven Mazurek who has a history of success and has been working hard behind the scenes with no dilution in over 2 years. Recently MSMY up listed to “pink current” status on OTC Markets and already has an eye on OTCQB. The Company has been making big moves having just signed a 1yr contract with Dr. CBD the number 1 brand on WeedMaps and has a contract with Susan Komen Cancer Org. and will be in big box retail stores in Southern California and test market is going very well. MSMY wholly owned subsidiary Eclipse Liquids is one of only 34 AEMSA certified and FDA registered clean room laboratories and production facilities for eLiquid private label manufacturing in the world. We will be updating on MSMY when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with MSMY.

Sign Up now for our 100% FREE Penny Stock Newsletter

Disclosure: we hold no position in MSMY either long or short and we have not been compensated for this article.

More articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest article

Sign up now for our 100% FREE Penny Stock Newsletter

Privacy Policy. we will never share your email with anyone.